PriceTargets.com logo

NYSE:UPH - UpHealth Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $12.67
  • Forecasted Upside: 104.30 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$6.20 As of 08/2/2021 01:00 AM ET
▼ -0.1 (-1.59%)

This chart shows the closing price for UPH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UpHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPH

Analyst Price Target is $12.67
▲ +104.30% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for UpHealth in the last 3 months. The average price target is $12.67, with a high forecast of $13.00 and a low forecast of $12.00. The average price target represents a 104.30% upside from the last price of $6.20.

This chart shows the closing price for UPH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in UpHealth.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/3/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/2/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/22/2021OppenheimerInitiated CoverageOutperform$12.00High
7/13/2021Colliers SecuritiesReiterated RatingBuy$13.00High
7/13/2021Northland SecuritiesInitiated CoverageOutperform$13.00High
6/8/2021Colliers SecuritiesReiterated RatingBuyHigh
(Data available from 8/2/2016 forward)
UpHealth logo
UpHealth, Inc. operates as a digital health services company. The company provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. It serves empowering providers, health systems, health plans and governments, employers, and educational institutions. The company is based in Delray Beach, Florida.
Read More

Today's Range

Now: $6.20
Low: $6.14
High: $6.68

50 Day Range

MA: N/A

52 Week Range

Now: $6.20
Low: $5.51
High: $12.12

Volume

282,488 shs

Average Volume

501,717 shs

Market Capitalization

$122.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.06

Frequently Asked Questions

What sell-side analysts currently cover shares of UpHealth?

The following Wall Street sell-side analysts have issued reports on UpHealth in the last twelve months: Colliers Securities, Northland Securities, and Oppenheimer Holdings Inc..
View the latest analyst ratings for UPH.

What is the current price target for UpHealth?

3 Wall Street analysts have set twelve-month price targets for UpHealth in the last year. Their average twelve-month price target is $12.67, suggesting a possible upside of 104.3%. Northland Securities has the highest price target set, predicting UPH will reach $13.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $12.00 for UpHealth in the next year.
View the latest price targets for UPH.

What is the current consensus analyst rating for UpHealth?

UpHealth currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UPH will outperform the market and that investors should add to their positions of UpHealth.
View the latest ratings for UPH.

What other companies compete with UpHealth?

Other companies that are similar to UpHealth include Virgin Group Acquisition Corp. II, Fortress Capital Acquisition, Northern Star Investment Corp. IV, AEA-Bridges Impact, Northern Star Investment Corp. III, TLG Acquisition One, Corner Growth Acquisition, Accelerate Acquisition, Cybin, Qell Acquisition, North Atlantic Acquisition, Altimeter Growth Corp. 2, KKR Acquisition Holdings I, Leo Holdings Corp. II and Khosla Ventures Acquisition Co. II.

How do I contact UpHealth's investor relations team?

UpHealth's physical mailing address is 1731 Embarcadero Road Suite 200, PALO ALTO CA, 94303. The company's listed phone number is 650-276-7040 and its investor relations email address is [email protected] The official website for UpHealth is www.gigcapital2.com.